Perkins Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $132K | Sell |
|
|||||
|
2017
Q3 | $210K | Sell |
|
|||||
|
2017
Q2 | $194K | Buy |
|
|||||
|
2017
Q1 | $199K | Buy |
|
|||||
|
2016
Q4 | $195K | Sell |
|
|||||
|
2016
Q3 | $451K | Sell |
|
|||||
|
2016
Q2 | $290K | Sell |
|
|||||
|
2016
Q1 | $396K | Sell |
|
|||||
|
2015
Q4 | $847K | Sell |
|
|||||
|
2015
Q3 | $1.07M | Sell |
|
|||||
|
2015
Q2 | $1.51M | Sell |
|
|||||
|
2015
Q1 | $697K | Buy |
|
|||||
|
2014
Q4 | $811K | Sell |
|
|||||
|
2014
Q3 | $892K | Sell |
|
|||||
|
2014
Q2 | $1.56M | Sell |
|
|||||
|
2014
Q1 | $1.47M | Sell |
|
|||||
|
2013
Q4 | $977K | Sell |
|
|||||
|
2013
Q3 | $1.24M | Buy |
|
|||||
|
2013
Q2 | $851K | Buy |
|